Research Article

Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database Analysis

Table 1

Patient characteristics of the study population.

Original datasetMatched dataset
Chemotherapy (n = 2760)(%)No chemotherapy or unknown (n = 1805)(%)Chemotherapy (n = 1607)(%)No chemotherapy or unknown (n = 1607)(%)

Age (years)<0.0011.000
 ≤501022 (37.0)271 (15.0)268 (16.7)269 (16.7)
 >501738 (63.0)1534 (85.0)1339 (83.3)1338 (83.3)
Race0.8120.725
 White2067 (74.9)1351 (74.8)1181 (73.5)1174 (73.1)
 Black454 (16.4)289 (16.0)281 (17.5)275 (17.1)
 Other/unknown239 (8.7)165 (9.1)145 (9.0)158 (9.8)
Year of diagnosis<0.0010.872
 2010-2011826 (29.9)663 (36.7)565 (35.2)555 (34.5)
 2012-2013980 (35.5)621 (34.4)568 (35.3)565 (35.2)
 2014-2015954 (34.6)521 (28.9)474 (29.5)487 (30.3)
Laterality0.9630.480
 Left1413 (51.2)922 (51.1)839 (52.2)818 (50.9)
 Right1347 (48.8)883 (48.9)768 (47.8)789 (49.1)
Primary site<0.0010.951
 Nipple/central73 (2.6)82 (4.5)53 (3.3)62 (3.9)
 UIQ472 (17.1)261 (14.5)236 (14.7)247 (15.4)
 LIQ192 (7.0)112 (6.2)112 (7.0)109 (6.8)
 UOQ982 (35.6)588 (32.6)541 (33.7)534 (33.2)
 LOQ214 (7.8)135 (7.5)128 (8.0)124 (7.7)
 Other827 (30.0)627 (34.7)537 (33.4)531 (33.0)
Histologic subtype<0.0010.144
 Ductal2464 (89.3)1488 (82.4)1381 (85.9)1341 (83.4)
 Lobular16 (0.6)21 (1.2)16 (1.0)20 (1.2)
 Other280 (10.1)296 (16.4)210 (13.1)246 (15.3)
Grade<0.0010.101
 1-2548 (19.9)671 (37.2)444 (27.7)503 (31.3)
 32156 (78.1)1078 (59.7)1119 (69.6)1054 (65.6)
 Unknown56 (2.0)56 (3.1)44 (2.7)50 (3.1)

Abbreviations indicate the breast quadrant. UIQ, upper-inner; LIQ, lower-inner; UOQ, upper-outer; LOQ, lower-outer.